Global Gene Panel Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Gene Panel Market was valued at $4.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 17.5% CAGR, to an estimated market size of $9.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global gene panel market involves the development and application of diagnostic tools that analyze multiple genes simultaneously to identify mutations, deletions, or duplications. These panels primarily utilize Next-Generation Sequencing (NGS) and other molecular techniques to provide actionable insights for clinical diagnostics, precision oncology, and hereditary disease management, offering a more cost-effective and targeted alternative to whole-genome sequencing.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Gene Panel Market in the period 2025-30:
- The ascendancy of precision oncology is driving the shift from single-gene testing to comprehensive multi-gene panels for targeted therapy selection.
- Continuous technological advancements in Next-Generation Sequencing (NGS) are significantly lowering the cost per sample and improving diagnostic yield.
- Integration of Artificial Intelligence (AI) and machine learning is streamlining the interpretation of complex genetic data and reducing the rate of variants of uncertain significance.
- Expansion of reimbursement policies by major insurers and government bodies is increasing the clinical adoption of large-scale panels for solid tumors.
- A growing trend toward decentralized testing is seeing hospital laboratories implement in-house NGS workflows to reduce turnaround times for critical patient results.
- The rise of liquid biopsy-based panels is enabling non-invasive monitoring of treatment response and early detection of cancer recurrence.
- Increasing demand for customized gene panels allows researchers and clinicians to tailor assays to specific patient populations or rare disease cohorts.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Oncology & Cancer Risk Assessment
- Congenital & Genetic Disorders
- Pharmacogenetics
- Other Applications